(NP -LCB-/-LRB- (NP-COOD (NP (NP Changes/NNS) (PP in/IN (NP (NP levels/NNS) (PP of/IN (NP (NP leucocytic/JJ estrogen/NN receptor/NN) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP menopausal/JJ type/NN II/CD diabetes/NNS))))))))) and/CC (NP its/PRP$ significance/NN)) -RCB-/-RRB-)
(S (NP-SBJ-43 (NP The/DT number/NN) (PP of/IN (NP (NP (NP estrogen/NN receptors/NNS) (PRN -LRB-/-LRB- (NP ER/NN) -RRB-/-RRB-)) (PP in/IN (NP (NP human/JJ peripheral/JJ leucocytes/NNS) (PP in/IN (NP (NP 12/CD women/NNS) (PP with/IN (NP menopausal/JJ type/NN II/CD diabetes/NNS))))))))) (VP was/VBD (VP measured/VBN (NP *-43/-NONE-) (PP with/IN (NP radio-ligand/JJ binding/NN method/NN)))) ./.)
(S (NP-SBJ-44 The/DT results/NNS) (VP were/VBD (VP compared/VBN (NP *-44/-NONE-) (PP with/IN (NP (NP those/DT) (PP of/IN (NP-COOD (NP (NP 12/CD menopausal/JJ women/NNS) (PP without/IN (NP diabetes/NNS))) and/CC (NP (NP 12/CD normal/JJ women/NNS) (PP of/IN (NP childbearing/JJ age/NN))))))))) ./.)
(S (NP-SBJ It/PRP) (VP was/VBD (VP found/VBN (SBAR that/IN (S (NP-SBJ-45 (NP the/DT number/NN) (PP of/IN (NP (NP ER/NN) (PP in/IN (NP the/DT patients/NNS))))) (VP was/VBD (ADVP significantly/RB) (VP decreased/VBN (NP *-45/-NONE-))))))) ./.)
(S (NP-SBJ Our/PRP$ data/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ (NP decrease/NN) (PP of/IN (NP (NP ER/NN level/NN) (PP in/IN (NP leukocytes/NNS))))) (VP may/MD (VP be/VB (ADJP-PRD related/JJ (PP to/TO (NP (NP the/DT pathogenesis/NN) (PP of/IN (NP type/NN II/CD diabetes/NNS)) (PP in/IN (NP menopausal/JJ period/NN)))))))))) ./.)
